- Reaction score
- 2,634
Forbes website is jenky crap, so don't bother clicking on the source link, I'll post the entire below:
Hollywood has made movies about it. Industries have made billions from it. And if the volume of scripture is any indication, the Almighty God must have placed great value on his creation of the head of human hair. After all, He gave Samson—the strongest man of whom the Bible tells—his immense strength through his hair and declared a woman’s hair "a glory unto" her in the 11thchapter of 1 Chorinthians.
Is it any wonder men and women obsess over their hair? And though we may get wiser as we age (a good thing), most of us don’t get hairier—at least not in the places we want to (not a good thing).
But there is a Canadian company who has been working diligently to change that. And if they’re right—and so far the research indicates they are—baldness may become a thing of the past for those who choose not to tolerate hair loss anymore. And they're not only attacking baldness, Aging skin and tendon degeneration are on the cutting block as well. It's great news for the tens of millions of older Americans who suffer from these malladies. But the most fascinating part lies in the source of the cure. It’s you. The company focuses on the development of cell therapies using a patient's own cells.
RepliCel is a regenerative medicine company focused on developing autologous cell therapies (or therapies that involve one individual as both donor and recipient) that address conditions linked to a deficit of healthy cells required for normal healing and function. Located in Vancouver, British Columbia, the company has developed first-of-their-kind cell therapies that will, they hope, treat conditions that now affect 1 in 3 Americans: pattern baldness, aging and sun-damaged skin, and chronic tendon degeneration.
Lee Buckler, CEO and director of RepliCel said cell-based therapies are now being called the “third pillar” of medicine. “First came small-molecule drugs produced by Big Pharma. Next came the genetic engineering revolution and targeted drugs developed by biotech firms. Finally, we have cell-based technologies,” he said.
RepliCel’s technology has proven to grow new hair without transplants, creams or pills because it’s using a patient’s own stem cells to regenerate hair. Buckler said the basis for the company’s science comes from research conducted in the early 2000s in Europe by noted hair biology and dermatology experts Dr. Kevin McElwee, PhD, and Dr. Rolf Hoffmann, MD, who originally discovered the critical cell responsible for hair follicle growth. It is now being tested in human Phase II trials that began in July 2016 in Japan. Two other products of the company are for conditions where there are too few healthy fibroblasts, such as chronic tendinosis and damaged skin.
“Regenerative medicine is a game-changing area of medicine with the potential to fully heal damaged tissues and organs, offering solutions and hope for people who have conditions that today are beyond repair,” Buckler said. “RepliCel is one of the most promising biotech companies to watch in the field of developing medical innovations that are life-changing.”
Buckler said it started in 2003 with the academic research of Hoffmann and McElwee at the University of Marburg in Marburg, Germany. At the time they were trying to understand what was happening in the hair follicles of people suffering from androgenetic alopecia—a common form of hair loss in both men and women—or the underlying cause of hair loss.
Source: https://www.forbes.com/sites/robins...ng-skin-and-tendon-degeneration/#5237d27f93f2
---------------------------
Not much is new in here though.
Hollywood has made movies about it. Industries have made billions from it. And if the volume of scripture is any indication, the Almighty God must have placed great value on his creation of the head of human hair. After all, He gave Samson—the strongest man of whom the Bible tells—his immense strength through his hair and declared a woman’s hair "a glory unto" her in the 11thchapter of 1 Chorinthians.
Is it any wonder men and women obsess over their hair? And though we may get wiser as we age (a good thing), most of us don’t get hairier—at least not in the places we want to (not a good thing).
But there is a Canadian company who has been working diligently to change that. And if they’re right—and so far the research indicates they are—baldness may become a thing of the past for those who choose not to tolerate hair loss anymore. And they're not only attacking baldness, Aging skin and tendon degeneration are on the cutting block as well. It's great news for the tens of millions of older Americans who suffer from these malladies. But the most fascinating part lies in the source of the cure. It’s you. The company focuses on the development of cell therapies using a patient's own cells.
RepliCel is a regenerative medicine company focused on developing autologous cell therapies (or therapies that involve one individual as both donor and recipient) that address conditions linked to a deficit of healthy cells required for normal healing and function. Located in Vancouver, British Columbia, the company has developed first-of-their-kind cell therapies that will, they hope, treat conditions that now affect 1 in 3 Americans: pattern baldness, aging and sun-damaged skin, and chronic tendon degeneration.
Lee Buckler, CEO and director of RepliCel said cell-based therapies are now being called the “third pillar” of medicine. “First came small-molecule drugs produced by Big Pharma. Next came the genetic engineering revolution and targeted drugs developed by biotech firms. Finally, we have cell-based technologies,” he said.
RepliCel’s technology has proven to grow new hair without transplants, creams or pills because it’s using a patient’s own stem cells to regenerate hair. Buckler said the basis for the company’s science comes from research conducted in the early 2000s in Europe by noted hair biology and dermatology experts Dr. Kevin McElwee, PhD, and Dr. Rolf Hoffmann, MD, who originally discovered the critical cell responsible for hair follicle growth. It is now being tested in human Phase II trials that began in July 2016 in Japan. Two other products of the company are for conditions where there are too few healthy fibroblasts, such as chronic tendinosis and damaged skin.
“Regenerative medicine is a game-changing area of medicine with the potential to fully heal damaged tissues and organs, offering solutions and hope for people who have conditions that today are beyond repair,” Buckler said. “RepliCel is one of the most promising biotech companies to watch in the field of developing medical innovations that are life-changing.”
Buckler said it started in 2003 with the academic research of Hoffmann and McElwee at the University of Marburg in Marburg, Germany. At the time they were trying to understand what was happening in the hair follicles of people suffering from androgenetic alopecia—a common form of hair loss in both men and women—or the underlying cause of hair loss.
Source: https://www.forbes.com/sites/robins...ng-skin-and-tendon-degeneration/#5237d27f93f2
---------------------------
Not much is new in here though.
